Document is current
Any future updates will be listed below
-
Authors
Guenther, Lyn https://orcid.org/0000-0001-9286-1534
Turchin, Irina https://orcid.org/0000-0001-8654-9050
Vender, Ron https://orcid.org/0000-0002-2624-2724
Albrecht, Lorne E. https://orcid.org/0000-0003-1718-884X
Maari, Catherine https://orcid.org/0000-0002-9719-0810
Yanofsky, Howard https://orcid.org/0000-0002-6473-4586
Prajapati, Vimal H. https://orcid.org/0000-0002-8315-2522
-
Funding
Funding for this research was provided by:
Bausch Health
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 31 May 2024
First Online: 25 June 2024
Declarations
:
: L. Guenther is on the Speaker’s Bureau of, a consultant for, and/or has received grant/research support from Abbvie, Altana, Amgen, Aslan, Bausch Health, Boehringer Ingelheim, BMS, Celgene, Eli Lilly and Company, Galderma, GSK, Innovaderm, Janssen, Leo Pharma, Merck Frosst, Novartis, Pfizer, Sandoz, Sun Pharma, and UCB. I. Turchin has been advisor, consultant, speaker and/or investigator for Abbvie, Amgen, Arcutis, Aristea, Bausch Health, BMS, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Galderma, Incyte, Janssen, Kiniksa, LEO Pharma, Mallinckrodt, Novartis, Pfizer, Sanofi Genzyme, Sun Pharma, and UCB. R. Vender has received grants and/or research support from, is on the Speaker’s Bureau for, received honoraria from, and/or is a consultant for Abbvie, Actelion, Amgen, Aralez, Arcutis, Bausch Health, Boehringer Ingelheim, BMS, Celgene, Centocor, Cipher, Dermira, Dermavant, Galderma, GSK, Innovaderm, Janssen, Kabi-Care, Leo, Eli Lilly and Company, Meiji, Merck, Novartis, Palladin, Pfizer, Regeneron, Sandoz, Sun Pharma, Takeda, UCB, and Viatris-Mylan. L. Albrecht is on the Speaker’s Bureau of, a consultant for, and/or has received grant/research support or honoraria from Abbvie, Akros, Amgen, Arcutis, Avillion, Bausch Health/Valeant, Boehringer Ingelheim, BMS, Celgene, Centocor, Cutanea, Dermavant, Dermira, Eli Lilly and Company, Galderma, Glenmark, Hoffman-La Roche, Janssen, LEO Pharma, MedImmune, Merck, Novartis, Pfizer, Regeneron, Sanofi Genzyme, UCB, and Valeant/Bausch Health. C. Maari has received honoraria from Bausch Health, Canada Inc. H. Yanofsky has received honoraria from Bausch Health, Canada Inc. V.H. Prajapati has been an advisor, consultant, speaker, and/or investigator for AbbVie, Actelion, Amgen, AnaptysBio, Apogee Therapeutics, Aralez, Arcutis, Arena, Asana, Aspen, Bausch Health/Valeant, Boehringer Ingelheim, BMS, Celgene, Cipher, Concert, CorEvitas, Dermavant, Dermira, Eli Lilly and Company, Galderma, GSK, Homeocan, Incyte, Janssen, LEO Pharma, Medexus, Nimbus Lakshmi, Novartis, Organon, Pediapharm, Pfizer, RAPT Therapeutics, Regeneron, Reistone, Sanofi Genzyme, Sun Pharma, Takeda, Tribute, and UCB.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
